Icos to manufacture GPC antibodies

ICOS will conduct development, scale-up and GMP manufacturing of anti-MHC class II antibodies from GPC Biotech (NMarkt:GPC) for use in GPC's B-cell lymphoma and immunology programs. GPC will retain al...